1. Blood asymmetric dimethylarginine and nitrite/nitrate concentrations in short-stature children born small for gestational age with and without growth hormone therapy
- Author
-
Ichiro Morioka, Takashi Miida, Kazumoto Iijima, Hironori Nagasaka, Mariko Nakacho, Satoshi Hirayama, Akihito Ishida, Mayuko Takuwa, Tohru Yorifuji, Hirokazu Tsukahara, and Mayumi Yoshida
- Subjects
Male ,Medicine (General) ,Asymmetric dimethylarginine ,Arginine ,030204 cardiovascular system & hematology ,Biochemistry ,chemistry.chemical_compound ,Basal (phylogenetics) ,small for gestational age ,0302 clinical medicine ,Longitudinal Studies ,Nitrite ,Child ,General Medicine ,growth hormone treatment ,Growth hormone treatment ,Child, Preschool ,Infant, Small for Gestational Age ,Female ,medicine.symptom ,medicine.medical_specialty ,Dwarfism ,030209 endocrinology & metabolism ,nitrite/nitrate ,Short stature ,Nitric oxide ,03 medical and health sciences ,R5-920 ,Internal medicine ,medicine ,Humans ,Nitrites ,amino acids ,Nitrates ,business.industry ,Biochemistry (medical) ,Infant, Newborn ,Research Reports ,Cell Biology ,medicine.disease ,Body Height ,short stature ,Endocrinology ,chemistry ,Case-Control Studies ,Growth Hormone ,Small for gestational age ,business ,Biomarkers - Abstract
Objective To investigate the basal amino acid metabolism and impact of growth hormone (GH) therapy in short-stature children born small for gestational age (short SGA children). Methods In this age-matched case-control study, the basal blood levels of amino acids, asymmetric dimethylarginine (ADMA), and nitrite/nitrate (NOx) were compared between 24 short SGA children and 25 age-matched normal children. Changes in these parameters were assessed for 12 months in 12 short SGA children initiating GH therapy (Group A) and 12 age-matched short SGA children without GH therapy (Group B). Results The arginine levels were significantly lower in the short SGA than in normal children. The ADMA levels were significantly higher and NOx levels were significantly lower in the short SGA than normal children. In Group A, the ADMA level was significantly lower and NOx level was significantly higher at 6 months than at baseline. At 12 months, the ADMA level in Group A began to increase, but the NOx level remained the same. Group B showed no significant changes. Conclusions This study is the first to show that ADMA is promoted and nitric oxide is suppressed in short SGA children and that GH therapy affects the production of ADMA and nitric oxide.
- Published
- 2018